by Team Small News | Mar 29, 2025 | Pharma, Zydus
Mumbai’s real estate sector is experiencing a surge, with a record number of high-value sales driven by billionaires, Bollywood celebrities, and high net-worth individuals. One recent example is the Zydus Family Trust, a major shareholder in Zydus Lifesciences,...
by Team Small News | Mar 18, 2025 | Pharma, Zydus
Zydus Lifesciences has obtained final approval from the US Food and Drug Administration (USFDA) to manufacture Apalutamide Tablets, also known as Erleada Tablets, 60 mg. The drug is an androgen receptor inhibitor, primarily used to treat patients with metastatic...
by Team Small News | Mar 16, 2025 | Pharma, Zydus
Zydus Lifesciences Ltd has successfully concluded a US Food and Drug Administration (USFDA) surveillance inspection at its API Unit 1 in Ankleshwar, Gujarat. The inspection, which took place from March 10 to 14, 2025, ended with “NIL observations,”...
by Team Small News | Mar 16, 2025 | Pharma, Zydus
The Central Drug Standard Control Organization (CDSCO) has suggested revising the phase III clinical trial protocol for Zydus Healthcare’s Empagliflozin plus Metoprolol Succinate fixed-dose combination (FDC). The CDSCO’s suggestion aims to enhance the...
by Team Small News | Mar 15, 2025 | Pharma, Zydus
Zydus Lifesciences, a leading pharmaceutical company, has successfully completed a USA Food and Drug Administration (USFDA) inspection at its Ankleshwar facility. This achievement demonstrates the company’s commitment to maintaining the highest standards of...
by Team Small News | Mar 14, 2025 | Pfizer, Pharma, Zydus
Zydus, an Indian pharmaceutical company, has made a significant move in the competitive field of sickle cell disease treatment by acquiring a stake in US-based Illexa, a company developing a once-daily oral treatment for the disease. This acquisition provides Zydus...